Copyright
©The Author(s) 2017.
World J Gastroenterol. Feb 14, 2017; 23(6): 964-975
Published online Feb 14, 2017. doi: 10.3748/wjg.v23.i6.964
Published online Feb 14, 2017. doi: 10.3748/wjg.v23.i6.964
Figure 5 Enhanced recovery of long-term cryopreserved intestinal organoids was dependent on the timing of Y-27632 treatment.
Undissociated organoids (P3) were treated with 10 μmol/L Y-27632 at the indicated time points. A: Representative morphology of organoids cultured on day 7 in the presence of ENR medium after thawing organoids cryopreserved for 3 mo in the presence of 10% DMSO. Scale bars, 200 μm. B: Quantification of recovery from cryopreserved organoids was performed using MTT assays. The data are shown as means ± SDs of triplicate experiments (bP < 0.01, two-way analysis of variance with Dunnett’s T3 tests) and normalized to untreated samples. MTT: Methyl thiazolyl tetrazolium; ENR: Epidermal growth factor/Noggin/R-spondin1.
- Citation: Han SH, Shim S, Kim MJ, Shin HY, Jang WS, Lee SJ, Jin YW, Lee SS, Lee SB, Park S. Long-term culture-induced phenotypic difference and efficient cryopreservation of small intestinal organoids by treatment timing of Rho kinase inhibitor. World J Gastroenterol 2017; 23(6): 964-975
- URL: https://www.wjgnet.com/1007-9327/full/v23/i6/964.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i6.964